Coverage
-
January 11, 2011
Pharmaceutical company Novo Nordisk Inc. has asked a judge to toss antitrust claims made by generic-drug maker Paddock Laboratories Inc. in an infringement dispute over Novo's diabetes drug Prandin, saying it is not to blame for Paddock's delayed market entry.
1 other articles on this case.
View all »